Hyalex Orthopaedics Appoints Carl Vause, Orthopaedic Industry Veteran, as Chief Executive Officer and President and Names Mike Hawkins, Ph.D., Chief Technical Officer
- Hyalex Orthopaedics
LEXINGTON, Mass., Jan. 25, 2022 /PRNewswire/ — Hyalex Orthopaedics, a privately-held medical device company developing transformational cartilage biomimetic products, today announced the appointment of Carl Vause as its new chief executive officer and president. Mr. Vause, who succeeds Hyalex’s interim president, Michael Hawkins, Ph.D., has also been appointed to the company’s board of directors. Additionally, Dr. Hawkins has been named chief technical officer and will continue to serve as a director on the company’s board. Read more…
Related Reading
Blog / Small Business / The MedTech Conference
AdvaMed in Action: Small Companies & Accel Members in the Spotlight at The MedTech Conference 2025
August 22, 2025
DeChane Dorsey, Executive Director of AdvaMed Accel and a leading voice for early-stage innovation, to explore why this year’s programming is especially critical for small companies and entrepreneurs.
News / Business Development
AdvaMed Welcomes Formation of New Medtech Company Targeting Gastrointestinal Treatments
July 25, 2025
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on the collaboration between Revival Healthcare Capital and Olympus Corporation to co-found Swan EndoSurgical, Inc. to develop a robotics platform to provide earlier, safer, and more effective treatment of lesions or tumors in the gastrointestinal tract relative to current therapeutic options.
News / Business Development / Government & Legislative Affairs / Small Business
AdvaMed Welcomes Introduction of American Innovation and Jobs Act
May 22, 2025
WASHINGTON—AdvaMed, the Medtech Association, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) and U.S. Reps. Kevin Hern (R-Okla.) and Mike Thompson (D-Calif.). The bill provides for Medicare and Medicaid coverage of evidence-based software applications used to prevent, manage, or treat medical conditions.
Resource / Business Development / Digital Health / Supply Chain
Accelerating Healthcare Solutions with B2B eCommerce
April 7, 2025
EPAM recently published a case study highlighting the rise of composable commerce solutions to enable B2B processes in the healthcare industry. This piece focuses on the experience of diagnostics company, Cepheid – a part of Danaher Corporation.
Blog / Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
March 28, 2025
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Resource / Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Health Access / Legal / Regulatory Affairs / Small Business
The Medical Innovation Agenda for the 119th Congress
March 13, 2025
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Resource / Business Development
Accelerated access to novel cancer therapies at Moores Cancer Center
November 27, 2024
Learn how the EY Clinical Trial Fast Lane solution helps jumpstart clinical trials in 45 to 60 working days through rapid performance of functional services, deep understanding of clinical trial operations, and more.
News / Government & Legislative Affairs / Small Business
AdvaMed® Statement on House Passage of Critical R&D Tax Provision
January 31, 2024
AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker upon the passage of a research and development expensing tax provision critical to medtech innovation in the House of Representatives.